Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales24 89032 63930 39025 85922 75321 908
EBITDA16 79423 66820 34717 37914 27213 457
Operating profit (EBIT)16 58023 39620 03316 07213 14312 547
Pre-Tax Profit (EBT)------
Net income12 10118 10813 50110 6078 4388 316
P/E ratio12,88,507,2010,0012,112,2
EPS ( $ )7,3511,99,948,006,616,54
Dividend per Share ( $ )-1,291,842,122,272,45
Yield-1,27%2,57%2,64%2,83%3,06%
Reference price ( $ )94.26101.1971.6180.0180.0180.01
Announcement Date02/03/2015
09:05pm
02/02/2016
09:00pm
02/07/2017
09:01pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt2 8117 573-12 3949 6638 059
Finance--32 380---
Operating income (EBITDA)16 79423 66820 34717 37914 27213 457
Leverage
(Debt/EBITDA)
0,17x0,32x-0,71x0,68x0,60x
Capital Expenditure557747748574532518
Book Value Per Share (BVPS)10,6 $13,2 $14,6 $20,2 $23,8 $26,6 $
Cash Flow per Share7,79 $12,9 $12,3 $9,69 $7,52 $7,31 $
Announcement Date02/03/2015
09:05pm
02/02/2016
09:00pm
02/07/2017
09:01pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 104 487 M$ -
Entreprise Value (EV) 116 881 M$ 114 150 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 10,00x 12,1x
Capitalization / Revenue 4,04x 4,59x
EV / Revenue 4,52x 5,02x
EV / EBITDA 6,73x 8,00x
Yield (DPS / Price) 2,64% 2,83%
Price to book (Price / BVPS) 3,96x 3,36x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 62,2% 57,8%
operating Leverage (Delta EBIT / Delta Sales) -1,33x -1,52x
Net Margin (Net Profit / Revenue) 41,0% 37,1%
ROA (Net Profit / Asset) 19,1% 14,5%
ROE (Net Profit / Equities) 58,4% 41,8%
Rate of Dividend 26,4% 34,3%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   2,22% 2,34%
Cash Flow / Sales 49,0% 43,2%
Capital Intensity (Assets / Sales) 2,14x 2,55x
Financial Leverage (Net Debt / EBITDA) 0,71x 0,68x
EPS & Dividend